SDZ 224-015

Modify Date: 2024-01-10 10:39:35

SDZ 224-015 Structure
SDZ 224-015 structure
Common Name SDZ 224-015
CAS Number 161511-45-1 Molecular Weight 652.52
Density N/A Boiling Point N/A
Molecular Formula C30H35Cl2N3O9 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SDZ 224-015


SDZ 224-015 is an orally active inhibitor of the interleukin-1 beta (IL-1β) converting enzyme and caspase-1. SDZ 224-015 possesses anti-COVID-19 activity, targeting Mpro (IC50 of 30 nM)[1][2].

 Names

Name SDZ 224-015

 SDZ 224-015 Biological Activity

Description SDZ 224-015 is an orally active inhibitor of the interleukin-1 beta (IL-1β) converting enzyme and caspase-1. SDZ 224-015 possesses anti-COVID-19 activity, targeting Mpro (IC50 of 30 nM)[1][2].
Related Catalog
In Vivo SDZ 224-015 (0.3-300 μg/kg) potently reduces carrageenin-induced paw oedema[2]. SDZ 224-015 (0.2-5 mg/kg, p.o.) displays analgesic activity in the Randall-Selitto yeast-inflamed paw pressure test, significant at a dose of 1 mg/kg[2].
References

[1]. Martin A Redhead, et al. Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19. Sci Rep. 2021 Jun 24;11(1):13208.

[2]. P R Elford, et al. Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1 beta converting enzyme. Br J Pharmacol. 1995 Jun;115(4):601-6.

 Chemical & Physical Properties

Molecular Formula C30H35Cl2N3O9
Molecular Weight 652.52
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.